688553 汇宇制药
2026/09 - 九个月
人民币(K¥)
2025/12
人民币(K¥)
2024/12
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
经营活动产生之现金流量净额58,35590,513242,95666,933194,060
投资活动产生之现金流量净额(56,279)130,789270,457233,348(181,034)
筹资活动产生之现金流量净额75,21799,949(86,299)122,298(99,990)
汇率变动对现金及现金等价物的影响(4,853)(726)671,641(161)
现金及现金等价物净增加/(减少)72,441320,525427,180424,219(87,125)
期初现金及现金等价物余额2,377,7692,057,2441,630,0641,205,8451,292,970
期末现金及现金等价物余额2,450,2102,377,7692,057,2441,630,0641,205,845